Medications Development for Substance Related Disorders (R01)
ArchivedNational Institutes of Health
Description
Purpose. The National Institute on Drug Abuse (NIDA) is soliciting grant (R01) applications to support a diverse array of preclinical and/or clinical research projects that accelerate the translational discovery/development of safe and effective medications for the treatment of substance-related disorders (SRDs), with the ultimate goal of moving closer to, or gaining FDA approval of medications for the treatment of these disorders. Mechanism of Support. This FOA will utilize the R01 award mechanism. Funds Available and Anticipated Number of Awards. It is anticipated that a total of 10 awards will be funded for a total of $10,000,000.
Who can apply
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities / Indian housing authorities
- Native American tribal organizations (other than Federally recognized)
- Nonprofits with 501(c)(3) status (other than higher education)
- Nonprofits without 501(c)(3) status (other than higher education)
- Private institutions of higher education
- For-profit organizations other than small businesses
- Small businesses
- Others
Contact
NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV
- PostedJan 25, 2010
- ClosesApr 29, 2010
- Award ceiling$1,000,000
- Program funding$10,000,000
- CFDA93.279
Pro insight
Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.
Unlock with Pro